Radiopharm Theranostics Limited - Bathi operasional EBITDA RADX
Radiopharm Theranostics (RADX) aims for dominance in nuclear medicine by expanding its portfolio of alpha and beta therapies. Tracking EBITDA, with chart data sourced from GURU.Markets, confirms stable flows, while the 0.00 level reflects the current profit magnitude. Supply security is guaranteed by strict control over isotope decay timelines. The development of innovative theranostics allows for the integration of diagnostics with the targeted destruction of tumors.
Radiopharm Theranostics (RADX) - rincian metrik lan laporan keuangan
- kuotasi saiki lan rata-rata prakiraan nilai:
- rincian nilai pasar emiten:
- indikator nilai buku ekuitas:
- data tingkat utang lan likuiditas finansial:
Rasio Kabeh Utang marang Dana Pribadi Radiopharm Theranostics|RADX - Utang jangka dawa marang modal|Utang jangka cendhak marang modal radiopharmtheranostics.com|RADX - Gunggung utang perusahaan|Rasio utang marang nilai buku Radiopharm Theranostics|RADX - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Radiopharm Theranostics|Likuiditas darurat radiopharmtheranostics.com
- statistik bathi lan rasio pasar:
RADX - Bathi resik perusahaan|Bathi forward Radiopharm Theranostics|RADX - Pangali P/E|Pangali mangsa ngarep rega marang bathi Radiopharm Theranostics Ltd|RADX - Pangali PEG|Pangali EV/EBITDA Radiopharm Theranostics|RADX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku Radiopharm Theranostics|RADX - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan radiopharmtheranostics.com|RADX - Wutah bathi resik saben saham ing taun iki|Dinamika bathi saben saham sing diarepake ing taun ngarep Radiopharm Theranostics
Ringkesan analitik perusahaan:Radiopharm Theranostics Ltd - RADX
For Radiopharm Theranostics (RADX), which is protected by patents for isotopes in nuclear medicine, monitoring operating profit in cash terms reflects the actual efficiency of drug commercialization. This indicator measures cash flow from core operations before depreciation, allowing investors to filter out speculative noise and assess the business's resilience to market shocks, thereby preventing overpayment for the asset during periods of high volatility.
Karo sapa Radiopharm Theranostics saingan
ONC - Bathi operasional sadurunge ngurangi amortisasi|HALO: Bathi operasional sadurunge ngurangi amortisasi|RVMD - Bathi operasional EBITDA|Ascentage Pharma (AAPG) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CG Oncology Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|URGN (UroGen) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Bicara Corp BCAX|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Personalis, Inc. (PSNL)|ERAS (erasca.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA DCTH (Delcath Systems)|Bathi operasional EBITDA Y-mAbs Therapeutics Inc YMAB|Aura Bio - Bathi operasional EBITDA|CADL (Candel Therapeutics) - Bathi operasional sadurunge amortisasi|ARAY: Bathi operasional EBITDA|SLS - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Actuate Therapeutics|Bathi sadurunge bunga, pajak, lan amortisasi Citius Oncology Inc. CTOR|Bathi sadurunge mbayar bunga, pajak, lan amortisasi TuHURA Biosciences, Inc. (HURA)|TARA: Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi operasional EBITDA FATE (Fate Therapeutics, Inc.)|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi WHWK|TScan - Bathi operasional EBITDA|CSBR - Bathi operasional EBITDA|xbiotech.com (XBIT) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CEL-SCI - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi OS Therapies Incorporated|Bathi operasional sadurunge ngurangi amortisasi Artiva (ARTV)|Bathi operasional sadurunge ngurangi amortisasi ANL (Adlai Nortye Ltd.)|VERU (Veru Inc) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Tempest Tx - Bathi operasional sadurunge ngurangi amortisasi|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi XLO (Xilio Therapeutics Inc)|Enochian BioSciences - Bathi operasional EBITDA|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi MURA (Mural Oncology plc)|KAPA: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi OnKure Therapeutics (OKUR)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi CytoMed Therapeutics Ltd|CRIS: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA APLM|Bathi operasional EBITDA tharimmune.com (THAR)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Advanced Biomed ADVB|GNPX: Bathi operasional sadurunge amortisasi|CLDI - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi sunshinebiopharma.com|xeneticbio.com (XBIO) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|SLRX - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge ngurangi amortisasi PPBT|AONC (AON) - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi operasional EBITDA BGNE|Pendapatan operasional sadurunge ngurangi amortisasi Checkpoint Therapeutics Inc|Bathi operasional EBITDA ELEV (Elevation Oncology)|ICAD - Bathi operasional sadurunge ngurangi amortisasi|IKNA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan operasional sadurunge ngurangi amortisasi Notable Labs Ltd NTBL|viracta.com (VIRX) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|MorphoSys Corporation - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|NAYA (NAYA Biosciences) - Bathi operasional EBITDA|Bathi operasional EBITDA ascentage.com
